|Templeton College: Oxford University|
|Harvard University, AB|
|Government & Economics|
Mr. Le focuses on investment opportunities in biopharmaceuticals, medical devices, enterprise software and advanced materials. Since joining WRF Capital, he has worked closely with the management teams and boards of Corus Pharma (acquired by Gilead Sciences), Lumera (NasdaqNM:LMRA), Performant (acquired by Mercury Interactive), and Point of CareWare. He represents WRF Capital as a Director of Accelerator Corp. and is a Board Observer at Alder Biopharmaceuticals, HaloSource, Hyperion Therapeutics, Teranode, Uptake Medical, and VLST Corp.
Prior to joining WRF Capital, Mr. Le was the founder, president and chief executive officer of MiniMeals, Inc. and a consultant for Capital Management Consulting, Inc., where his clients included Fortune 500 companies, entrepreneurial teams, and top-tier venture capital firms. Earlier, he was at Raymond James & Associates, Singer & Xenos Investment Management Company and Capital Management Group LLC, a private investment firm specializing in biomedical ventures.
Mr. Le completed post-graduate studies at the Templeton College of Oxford University and earned a bachelor of arts cum laude in economics and government from Harvard University. He serves as the Pacific Northwest Regional Director for the Harvard Alumni Association, as a member of the Advisory Council for the National Venture Capital Association (NVCA), and as a Board Member for the Washington Biotechnology & Biomedical Association (WBBA). He was also recently named one of the regions “40 Under 40” by the Puget Sound Business Journal.